Skip to main content
Caplight Logo









Aqtual

Aqtual

Private
Hayward, CaliforniaHealthcare & Life Scienceshttps://aqtual.com/

Last Round

Series B

Jul 10, 2025

Total Funding Raised

$47M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Aqtual is a biotechnology company that develops precision medicine products for chronic disease management and oncology using a novel cell-free DNA-based platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics, Clinical Trials

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Application

Keywords

precision medicinecell-free DNAcfDNAliquid biopsyepigeneticsdiagnostic platformbiotechnologytranscriptomicstherapy response predictiononcology diagnosticsclinical decision supporthealthcare analyticsbiomarker discoverymolecular diagnosticsmulti-omics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aqtual Comparables

Compare Aqtual with similar companies based on industry and business-model similarity.

Aqtual comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Precede
85%
Adela
83%
Scipher Medicine
81%

Aqtual Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 10, 2025
Series AOct 31, 2023

Key People

Founding team and executive leadership

Diana Abdueva

Founder CEO

Founding Team

Ferhan Qureshi

Chief Technology Officer

Executive Team

Aqtual Investors

Notable investors and investment history

Aqtual investors
InvestorRounds
Genoa VenturesSeries B, Series A
BOLD Capital PartnersSeries B
Manta Ray VenturesSeries B, Series A
Yu GalaxySeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 54% MoM, reaching 2.5K.

  • Jul 10, 2025

    $31M round completed.

Aqtual Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aqtual Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aqtual's valuation, stock price, and market status.

Firmographic Details

HeadquartersHayward, California
Employee Range35
Year Founded2018
Last FundingJul 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?